Intern - Corporate Strategy And M&A

Fresenius Kabi

Feb 4

Applications are closed

Internship
Full-time
Off-cycle Internship
Business, Operations & Strategy
Chicago

Requirements

Intern candidates must be permanently authorized to work in the U.S.
Our internships are unable to accommodate OPT.
Interns are responsible for their own housing.
Ideal candidates will combine technical and business knowledge with analytical strength and creative problem-solving abilities.
Complete 2+ years of college education before beginning internship, must be enrolled in school the semester following your internship.
Pursuing a bachelor’s degree in business/finance or related business field at an accredited 4 year university.
Minimum GPA of 3.0 on a 4.0 scale.
Intermediate skills in Microsoft Excel, Word, and Power Point.
Self-starter and someone who takes full ownership over work product, must be able to think analytically, innovatively, and strategically with a desire for learning.
Also open to engineers and health-field related applicants if they were interested in M&A.

Responsibilities

Analyze markets, segments, sectors, companies/assets including startups across all Fresenius business areas and identify targets for inorganic growth.
Prepare pitch documents for management to create alignment and support prioritization efforts related to inorganic targets.
Assist with target asset valuations using various industry relevant valuation mechanisms such as DCF, NPV and precedent analysis.
Assist with company target presentations, company research/analyses and annual M&A strategic projects as needed.
Process/template improvement projects.
Capstone project and output presentation to be aligned with manager post-hire.

Fresenius Kabi

Manufacturing & Electronics

Industry

10,001+

Employees

1912

Founded Year

Mission & Purpose

Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The company’s products and services are used for the therapy and care of critically and chronically ill patients. Its product portfolio comprises a range of highly complex biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs. Within biopharmaceuticals, Fresenius Kabi offers, among others, biosimilar drugs with a focus on autoimmune diseases and oncology. The company’s clinical nutrition offering includes a wide selection of enteral and parenteral nutrition products. In the segment of medical technologies, its offering includes vital disposables, infusions pumps, apheresis machines, cell therapy devices, and more. Fresenius Kabi puts essential medicines and technologies in the hands of people who help patients and finds the best answers to the challenges they face. Following its “Vision 2026”, the company is furthermore committed to increase efficiencies in the therapy and care of patients and improve access to high-quality healthcare around the globe. Fresenius Kabi aspires to be leading globally in its product segments – all for the benefit of patients, its customers, and its stakeholders.